BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 46 minutes ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 50 minutes ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 56 minutes ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 3 hours ago Atmus Welcomes Heath Sharp to Board of Directors 5 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 5 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 46 minutes ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 50 minutes ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 56 minutes ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 3 hours ago Atmus Welcomes Heath Sharp to Board of Directors 5 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 5 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
Analysis

Ispire Technology Shares Move After Q2 Revenue Falls; Loss Narrows on Cost Cuts

$ISPR February 6, 2026 2 min read

Stock Performance and 52-Week Context

Ispire Technology Inc. (NASDAQ: ISPR) shares moved during intraday trading. For instance, this followed the fiscal second-quarter 2026 results release. Meanwhile, the stock stayed in a volatile 52-week range. Weak cannabis hardware demand created pressure. Ongoing restructuring actions fueled ups and downs. However, no analyst changes or price-target updates came with earnings.

Quarterly Financial Performance

Ispire posted $20.3 million in revenue for the quarter ended December 31, 2025. As a result, this dropped from $41.8 million a year earlier. Gross profit fell to $3.5 million from $7.7 million. Consequently, gross margin squeezed to 17.1% from 18.5%. Operating expenses dropped sharply to $10.3 million. They had hit $15.1 million before. These cuts reflected strong cost reductions. At the same time, net loss narrowed to $6.6 million from $8.0 million. Management explained the dip clearly. For example, they shifted from low-quality cannabis customers. Instead, they chased higher-quality revenue streams.

Billings, Cash Flow, and Balance Sheet

The company focused on collections and tight working-capital control. For instance, net accounts receivable plunged 19.5% to $37.9 million. This improved from $47.0 million at fiscal 2025’s end. Cash held steady at $17.6 million on December 31, 2025. Plus, management highlighted faster payment cycles. They also praised stronger cash collections.

Six-Month Performance

For the six months ended December 31, 2025, revenue totaled $50.6 million. Unfortunately, it fell from $81.2 million a year ago. Gross profit landed at $8.6 million, down from $15.4 million. Fortunately, net loss improved year over year. Lower costs and reduced credit losses drove this gain.

Full-Year Context and Strategic Actions

In fiscal 2025, Ispire generated $127.5 million in revenue. This declined from $151.9 million in fiscal 2024. Gross margin stayed at 17.8%. Today, the company advances cost cuts. It rationalizes customers too. Additionally, it expands manufacturing in Malaysia. Overall, these moves support future growth.

ADVERTISEMENT

Outlook Commentary

Executives labeled the quarter an “inflection point.” This marked the end of a year-long restructuring. As changes take hold, they expect better cash flow. They also predict stronger profitability soon.

ADVERTISEMENT